Abstract
Purpose
Optical redox imaging (ORI), based on collecting the endogenous fluorescence of reduced nicotinamide adenine dinucleotide (NADH) and oxidized flavoproteins (Fp) containing a redox cofactor flavin adenine dinucleotide (FAD), provides sensitive indicators of cellular metabolism and redox status. ORI indices (such as NADH, FAD, and their ratio) have been under investigation as potential progression/prognosis biomarkers for cancer. Higher FAD redox ratio (i.e., FAD/(FAD + NADH)) has been associated with higher invasive/metastatic potential in tumor xenografts and cultured cells. This study is to examine whether ORI indices can respond to the modulation of oncogene DEK activities that change cancer cell invasive/metastatic potential.
Procedures
Using lentiviral shRNA, DEK gene expression was efficiently knocked down in MDA-MB-231 breast cancer cells (DEKsh). These DEKsh cells, along with scrambled shRNA-transduced control cells (NTsh), were imaged with a fluorescence microscope. In vitro invasive potential of the DEKsh cells and NTsh cells was also measured in parallel using the transwell assay.
Results
FAD and FAD redox ratios in polyclonal cells with DEKsh were significantly lower than that in NTsh control cells. Consistently, the DEKsh cells demonstrated decreased invasive potential than their non-knockdown counterparts NTsh cells.
Conclusions
This study provides direct evidence that oncogene activities could mediate ORI-detected cellular redox state.
Similar content being viewed by others
References
Li LZ (2012) Imaging mitochondrial redox potential and its possible link to tumor metastatic potential. J Bioenerg Biomembr 44:645–653
Xu HN, Li LZ (2014) Quantitative redox imaging biomarkers for studying tissue metabolic state and its heterogeneity. J Innov Opt Health Sci 7:1430002
Alzbeta C, Dusan C (2014) Tissue fluorophores and their spectroscopic characteristics. In Fluorescence lifetime spectroscopy and imaging. CRC Press, Boca Raton, pp 47–84
Chance B, Schoener B, Oshino R, Itshak F, Nakase Y (1979) Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J Biol Chem 254:4764–4771
Li LZ, Xu HN, Ranji M, Nioka S, Chance B (2009) Mitochondrial redox imaging for cancer diagnostic and therapeutic studies. J Innov Opt Health Sci 2:325–341
Ozawa K, Chance B, Tanaka A, Iwata S, Kitai T, Ikai I (1992) Linear correlation between acetoacetate/beta-hydroxybutyrate in arterial blood and oxidized flavoprotein/reduced pyridine nucleotide in freeze-trapped human liver tissue. Biochim Biophys Acta 1138:350–352
Varone A, Xylas J, Quinn KP, Pouli D, Sridharan G, McLaughlin-Drubin ME, Alonzo C, Lee K, Munger K, Georgakoudi I (2014) Endogenous two-photon fluorescence imaging elucidates metabolic changes related to enhanced glycolysis and glutamine consumption in precancerous epithelial tissues. Cancer Res 74:3067–3075
Li LZ, Sun N (2014) Autofluorescence perspective of cancer diagnostics. In: Ghukasyan V, Heikal AA (eds) Natural biomarkers for cellular metabolism: biology, techniques, and applications. CRC Press, New York, pp 273–297
Kolenc OI, Quinn KP (2018) Evaluating cell metabolism through autofluorescence imaging of NAD(P)H and FAD. Antioxid Redox Signal. https://doi.org/10.1089/ars.2017.7451
Li LZ, Zhou R, Xu HN, Moon L, Zhong T, Kim EJ, Qiao H, Reddy R, Leeper D, Chance B, Glickson JD (2009) Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A 106:6608–6613
Xu HN, Tchou J, Feng M, Zhao H, Li LZ (2016) Optical redox imaging indices discriminate human breast cancer from normal tissues. J Biomed Opt 21:114003
Xu HN, Nioka S, Glickson JD, Chance B, Li LZ (2010) Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt 15:036010
Walsh A, Cook RS, Rexer B, Arteaga CL, Skala MC (2012) Optical imaging of metabolism in HER2 overexpressing breast cancer cells. Biomed Optics Express 3:75–85
Ostrander JH, McMahon CM, Lem S et al (2010) Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res 70:4759–4766
Sun N, Xu HN, Luo Q, Li LZ (2016) Potential indexing of the invasiveness of breast cancer cells by mitochondrial redox ratios. Adv Exp Med Biol 923:121–127
Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85–95
DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2:e1600200
Xu HN, Feng M, Moon L et al (2013) Redox imaging of the p53-dependent mitochondrial redox state in colon cancer ex vivo. J Innov Opt Health Sci 6:1350016
Xu HN, Nioka S, Li LZ (2013) Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res 1:6
Privette Vinnedge LM, McClaine R, Wagh PK, Wikenheiser-Brokamp KA, Waltz SE, Wells SI (2011) The human DEK oncogene stimulates beta-catenin signaling, invasion and mammosphere formation in breast cancer. Oncogene 30:2741–2752
Yu L, Huang X, Zhang W, Zhao H, Wu G, Lv F, Shi L, Teng Y (2016) Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget 7:26844–26855
Privette Vinnedge LM, Benight NM, Wagh PK, Pease NA, Nashu MA, Serrano-Lopez J, Adams AK, Cancelas JA, Waltz SE, Wells SI (2015) The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers. Oncogene 34:2325–2336
Matrka MC, Cimperman KA, Haas SR, Guasch G, Ehrman LA, Waclaw RR, Komurov K, Lane A, Wikenheiser-Brokamp KA, Wells SI (2018) Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence. PLoS Genet 14:e1007227
Liu G, Xiong D, Zeng J et al (2017) Prognostic role of DEK in human solid tumors: a meta-analysis. Oncotarget 8:98985–98992
Ying G, Wu Y (2015) DEK: a novel early screening and prognostic marker for breast cancer. Mol Med Rep 12:7491–7495
Lin Z, Xu HN, Wang Y, Floros J, Li LZ (2018) Differential expression of PGC1alpha in intratumor redox subpopulations of breast cancer. Adv Exp Med Biol 1072:177–181
Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, Munger K, Wells SI (2005) The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol 79:14309–14317
Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade M, Garner C, Digman MA, Teitell MA, Edwards RA, Gratton E, Waterman ML (2014) Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 33:1454–1473
Matrka MC, Watanabe M, Muraleedharan R, Lambert PF, Lane AN, Romick-Rosendale LE, Wells SI (2017) Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis. PLoS One 12:e0177952
Walsh AJ, Cook RS, Sanders ME, Aurisicchio L, Ciliberto G, Arteaga CL, Skala MC (2014) Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. Cancer Res 74:5184–5194
Alhallak K, Rebello LG, Muldoon TJ, Quinn KP, Rajaram N (2016) Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism. Biomed Opt Express 7:4364–4374
Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ, Yagi T, Felding-Habermann B (2013) Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest 123:1068–1081
Kunz WS (1988) Evaluation of electron-transfer flavoprotein and alpha-lipoamide dehydrogenase redox states by two-channel fluorimetry and its application to the investigation of beta-oxidation. Biochim Biophys Acta 932:8–16
Kunz WS, Gellerich FN (1993) Quantification of the content of fluorescent flavoproteins in mitochondria from liver, kidney cortex, skeletal muscle, and brain. Biochem Med Metab Biol 50:103–110
Rehman AU, Anwer AG, Gosnell ME, Mahbub SB, Liu G, Goldys EM (2017) Fluorescence quenching of free and bound NADH in HeLa cells determined by hyperspectral imaging and unmixing of cell autofluorescence. Biomed Opt Express 8:1488–1498
Banerjee R (2008) Redox biochemistry. John Wiley & Sons, Hoboken
Holmgren A (1989) Thioredoxin and glutaredoxin systems. J Biol Chem 264:13963–13966
Jorgenson TC, Zhong W, Oberley TD (2013) Redox imbalance and biochemical changes in cancer. Cancer Res 73:6118–6123
Acknowledgments
The authors thank Ms. Jinxia Jiang for her assistance in part of the data acquisition and Dr. Zhenwu Lin for valuable discussion and support. The authors would also like to appreciate the valuable discussion with and support from Dr. Andrea Stout and Ms. Jasmine Zhao of Cell and Developmental Biology Microscopy Core, Perelman School of Medicine, University of Pennsylvania.
Funding
This work was financially supported by the NIH Grant R01CA191207 (L.Z. Li) and NIH grant R37CA218072 (LMPV).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 81.2 kb)
Rights and permissions
About this article
Cite this article
Wen, Y., Xu, H.N., Privette Vinnedge, L. et al. Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 Breast Cancer Cells. Mol Imaging Biol 21, 410–416 (2019). https://doi.org/10.1007/s11307-019-01321-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-019-01321-w